German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer

Standard

German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer. / Hoffmann, Jürgen; Souchon, Rainer; Lebeau, Annette; Öhlschlegel, Christian; Gruber, Günther; Rageth, Christoph; Weber, Walter; Harbeck, Nadia; Janni, Wolfgang; Kreipe, Hans; Fitzal, Florian; Resch, Alexandra; Bago-Horvath, Zsuzsanna; Peintinger, Florentia; AGO.

In: EUR J CANCER, Vol. 49, No. 10, 01.07.2013, p. 2277-83.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Hoffmann, J, Souchon, R, Lebeau, A, Öhlschlegel, C, Gruber, G, Rageth, C, Weber, W, Harbeck, N, Janni, W, Kreipe, H, Fitzal, F, Resch, A, Bago-Horvath, Z, Peintinger, F & AGO 2013, 'German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer', EUR J CANCER, vol. 49, no. 10, pp. 2277-83. https://doi.org/10.1016/j.ejca.2013.01.034

APA

Hoffmann, J., Souchon, R., Lebeau, A., Öhlschlegel, C., Gruber, G., Rageth, C., Weber, W., Harbeck, N., Janni, W., Kreipe, H., Fitzal, F., Resch, A., Bago-Horvath, Z., Peintinger, F., & AGO (2013). German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer. EUR J CANCER, 49(10), 2277-83. https://doi.org/10.1016/j.ejca.2013.01.034

Vancouver

Bibtex

@article{5d33fb26251b4c92b06686456deb5f34,
title = "German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer",
abstract = "The German, Austrian and Swiss (D.A.CH) Societies of Senology gathered together in 2012 to address dwelling questions regarding axillary clearance in breast cancer patients. The Consensus Panel consisted of 14 members of these societies and included surgical oncologists, gynaecologists, pathologists and radiotherapists. With regard to omitting axillary lymph node dissection in sentinel lymph node macrometastases, the Panel consensually accepted this option for low-risk patients only. A simple majority voted against extending radiotherapy to the axilla after omitting axillary dissection in N1 disease. Consensus was yielded for the use of axillary ultrasound and prospective registers for such patients in the course of follow-up. The questions regarding neoadjuvant therapy and the timing of sentinel lymph node biopsy failed to yield consensus, yet both options (before or after) are possible in clinically node-negative disease.",
keywords = "Austria, Axilla, Breast Neoplasms, Female, Germany, Humans, Lymph Node Excision, Lymphatic Metastasis, Neoadjuvant Therapy, Sentinel Lymph Node Biopsy, Switzerland",
author = "J{\"u}rgen Hoffmann and Rainer Souchon and Annette Lebeau and Christian {\"O}hlschlegel and G{\"u}nther Gruber and Christoph Rageth and Walter Weber and Nadia Harbeck and Wolfgang Janni and Hans Kreipe and Florian Fitzal and Alexandra Resch and Zsuzsanna Bago-Horvath and Florentia Peintinger and AGO",
note = "Copyright {\textcopyright} 2013 Elsevier Ltd. All rights reserved.",
year = "2013",
month = jul,
day = "1",
doi = "10.1016/j.ejca.2013.01.034",
language = "English",
volume = "49",
pages = "2277--83",
journal = "EUR J CANCER",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "10",

}

RIS

TY - JOUR

T1 - German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer

AU - Hoffmann, Jürgen

AU - Souchon, Rainer

AU - Lebeau, Annette

AU - Öhlschlegel, Christian

AU - Gruber, Günther

AU - Rageth, Christoph

AU - Weber, Walter

AU - Harbeck, Nadia

AU - Janni, Wolfgang

AU - Kreipe, Hans

AU - Fitzal, Florian

AU - Resch, Alexandra

AU - Bago-Horvath, Zsuzsanna

AU - Peintinger, Florentia

AU - AGO

N1 - Copyright © 2013 Elsevier Ltd. All rights reserved.

PY - 2013/7/1

Y1 - 2013/7/1

N2 - The German, Austrian and Swiss (D.A.CH) Societies of Senology gathered together in 2012 to address dwelling questions regarding axillary clearance in breast cancer patients. The Consensus Panel consisted of 14 members of these societies and included surgical oncologists, gynaecologists, pathologists and radiotherapists. With regard to omitting axillary lymph node dissection in sentinel lymph node macrometastases, the Panel consensually accepted this option for low-risk patients only. A simple majority voted against extending radiotherapy to the axilla after omitting axillary dissection in N1 disease. Consensus was yielded for the use of axillary ultrasound and prospective registers for such patients in the course of follow-up. The questions regarding neoadjuvant therapy and the timing of sentinel lymph node biopsy failed to yield consensus, yet both options (before or after) are possible in clinically node-negative disease.

AB - The German, Austrian and Swiss (D.A.CH) Societies of Senology gathered together in 2012 to address dwelling questions regarding axillary clearance in breast cancer patients. The Consensus Panel consisted of 14 members of these societies and included surgical oncologists, gynaecologists, pathologists and radiotherapists. With regard to omitting axillary lymph node dissection in sentinel lymph node macrometastases, the Panel consensually accepted this option for low-risk patients only. A simple majority voted against extending radiotherapy to the axilla after omitting axillary dissection in N1 disease. Consensus was yielded for the use of axillary ultrasound and prospective registers for such patients in the course of follow-up. The questions regarding neoadjuvant therapy and the timing of sentinel lymph node biopsy failed to yield consensus, yet both options (before or after) are possible in clinically node-negative disease.

KW - Austria

KW - Axilla

KW - Breast Neoplasms

KW - Female

KW - Germany

KW - Humans

KW - Lymph Node Excision

KW - Lymphatic Metastasis

KW - Neoadjuvant Therapy

KW - Sentinel Lymph Node Biopsy

KW - Switzerland

U2 - 10.1016/j.ejca.2013.01.034

DO - 10.1016/j.ejca.2013.01.034

M3 - SCORING: Journal article

C2 - 23490652

VL - 49

SP - 2277

EP - 2283

JO - EUR J CANCER

JF - EUR J CANCER

SN - 0959-8049

IS - 10

ER -